Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2016-0348
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Cross-site request forgery (CSRF) vulnerability in IBM TRIRIGA Application Platform 3.3, 3.3.1, 3.3.2, and 3.4 allows remote attackers to hijack the authentication of arbitrary users for requests that insert XSS sequences. IBM X-Force ID: 111813.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM TRIRIGA Application Platform 跨站请求伪造漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM TRIRIGA Application Platform是美国IBM公司的一套用于部署TRIRIGA应用的技术平台。该平台提供了一组设计时和运行时组件,分别用于构建和运行其企业级应用,并支持客户特定的配置,而无需更改源代码。 IBM TRIRIGA Application Platform中存在跨站请求伪造漏洞,该漏洞源于程序没有正确的过滤用户提交的输入。远程攻击者可通过诱使用户访问恶意的网站利用该漏洞实施跨站脚本攻击,造成Web缓存中毒,执行其他恶意的操作。以下版本受到影响:IBM TRIRIG
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2016-0348
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2016-0348
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2016-0348

No comments yet


Leave a comment